Regulatory News April

COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets

EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU

EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19

Pharmacovigilance Risk Assessment Committee (PRAC) COVID-19-related highlights